• Revisiting bleomycin from pathophysiology to safe clinical use 

      Froudarakis, M.; Hatzimichael, E.; Kyriazopoulou, L.; Lagos, K.; Pappas, P.; Tzakos, A. G.; Karavasilis, V.; Daliani, D.; Papandreou, C.; Briasoulis, E. (2013)
      Bleomycin is a key component of curative chemotherapy regimens employed in the treatment of curable cancers, such as Hodgkin lymphoma (HL) and testicular germ-cell tumours (GCT), yet its use may cause bleomycin-induced ...
    • Talc pleurodesis in malignant pleural effusion: a systematic review and meta-analysis 

      Beltsios E.T., Mavrovounis G., Adamou A., Panagiotopoulos N. (2021)
      Objective: Malignant pleural effusion is a severe and common complication in patients with primary or metastatic malignancies of the pleura. Although talc pleurodesis is widely used for managing malignant pleural effusions, ...